LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)

Hong Kong · Delayed Price · Currency is HKD

12.47

+0.30 (2.47%)

Sep 30, 2026, 4:08 PM HKT

Market Cap	4.27B -39.7%
Revenue (ttm)	586.91M -7.9%
Net Income	235.80M -28.9%
EPS	0.68 -29.1%
Shares Out	342.13M
PE Ratio	18.38
Forward PE	7.40
Dividend	0.58 (4.68%)
Ex-Dividend Date	May 27, 2026

Volume	167,000
Open	12.60
Previous Close	12.17
Day's Range	12.35 - 12.63
52-Week Range	8.33 - 21.22
Beta	-0.20
Analysts	Strong Buy
Price Target	29.61 (+137.45%)
Est. Earnings	Nov 20, 2026

About HKG:2291

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices. It operates through Occluder Business and Heart Valve Business segments. The company also researches, develops, manufacture, and sale interventional treatment series occluders for defective congenital heart disease; and manufacture and sale heart valve medical devices. Its products include atrial septal defect, ventricular septal defect, patent du... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1994

Employees 371

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2291

Full Company Profile

Financial Performance

In 2025, HKG:2291's revenue was 527.94 million, an increase of 11.94% compared to the previous year's 471.64 million. Earnings were 239.73 million, a decrease of -2.37%.

Financial numbers in CNY Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 2291 stock is "Strong Buy." The 12-month stock price target is $29.61, which is an increase of 137.45% from the latest price.

Price Target

$29.61

(137.45% upside)

Analyst Consensus: Strong Buy

Stock Forecasts